V CompBrief BY VELARION

Independent Director · CG Oncology, Inc. (CGON)

Chair, Audit Committee

Susan Graf director compensation at CG Oncology (FY2025): $483K

Fiscal year 2025 director compensation for Susan Graf at CG Oncology, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Susan Graf’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Susan Graf and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

CG Oncology Director Compensation Table · all 2 fiscal years held
In US dollars, as CG Oncology reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$70,000$0$412,627$0$482,627
FY2024$58,435—$397,460$0$455,895

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CG Oncology, Inc. DEF 14A filed April 24, 2026, accession 0001193125-26-177395, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CG Oncology, Inc. filed document, accession 0001193125-26-177395. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

Get the CG Oncology Board Governance Report

$482,627 Susan Graf, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 24, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

CG Oncology pays directors a $45,000 cash retainer and $400,000 in Options.

Committees

FY2025 · as the proxy prints them

Audit (Chair) · Nominating/Governance

The rest of the CG Oncology board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Brian Liu, M.DIndependent Director$475,127
Christina RossiIndependent Director$575,150
James J. Mulé, Ph.DIndependent Director$457,627
Leonard Post, Ph.DLead Independent Director$500,127
Victor Tong JrIndependent Director$467,627

The full CG Oncology compensation record

free company brief
CG Oncology, Inc. (CGON) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within CG Oncology's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the CG Oncology proxy · each links to its own free brief

Order CGON

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report